Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00112073
Recruitment Status : Completed
First Posted : May 30, 2005
Last Update Posted : March 14, 2012
Information provided by (Responsible Party):
JANSSEN Alzheimer Immunotherapy Research & Development, LLC